BiomX Inc. (NYSEAMERICAN:PHGE – Get Free Report) shares dropped 0.7% during trading on Monday . The stock traded as low as $0.87 and last traded at $0.87. Approximately 27,301 shares traded hands during mid-day trading, a decline of 74% from the average daily volume of 105,003 shares. The stock had previously closed at $0.88.
BiomX Stock Down 5.9 %
The company has a market cap of $14.32 million, a P/E ratio of -0.20 and a beta of 1.29.
BiomX (NYSEAMERICAN:PHGE – Get Free Report) last released its quarterly earnings results on Wednesday, August 14th. The company reported $0.70 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($1.20) by $1.90. On average, equities research analysts forecast that BiomX Inc. will post -2.7 EPS for the current year.
About BiomX
BiomX Inc, a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC).
Featured Articles
- Five stocks we like better than BiomX
- Where Do I Find 52-Week Highs and Lows?
- Boeing: Why Analysts Think Now’s The Time To Be Brave
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Advanced Micro Devices is Building Momentum with AI: Buy the Dip
- How to Buy Cheap Stocks Step by Step
- Can Evolv Stock Recover From Its Massive Self-Inflicted Drop?
Receive News & Ratings for BiomX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BiomX and related companies with MarketBeat.com's FREE daily email newsletter.
